New Diagnostic Tests: Breakthrough Approaches or Expensive Add-ons?

Richard A. Deyo, Jeffrey J. Jarvik

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Gould and colleagues' state-of-the-art meta-analysis on the accuracy of positron emission tomography (PET) scanning for mediastinal staging in patients with non-small-cell lung cancer supports its use. However, the effect of PET scanning on patient outcomes is unknown, which is a major shortcoming of the evidence needed to support its wider use. Improved test sensitivity and specificity alone are not enough.

Original languageEnglish (US)
Pages (from-to)950-951
Number of pages2
JournalAnnals of internal medicine
Issue number11
StatePublished - Dec 2 2003

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'New Diagnostic Tests: Breakthrough Approaches or Expensive Add-ons?'. Together they form a unique fingerprint.

Cite this